Evotec Strengthens its Ion Channel Capabilities to Support new Alliances
News Jun 30, 2009
Evotec AG has announced the expansion of its ion channel capabilities with the addition of ion channel focused libraries and additional electrophysiology screening platforms.
The libraries will be integrated into Evotec’s screening library, providing Evotec’s screening partners access to a high quality, diverse and highly relevant screening library for high-throughput screening collaborations, including the screening of ion channel targets.
Furthermore, Evotec has increased its considerable capability in ion channel screening through the addition of a Sophion Q-Patch electrophysiology platform as well as manual rigs equipped with Cellectricon’s Dynaflow® perfusion electrophysiology system.
This instrumentation will expand Evotec’s capabilities in ion channel screening which already includes an IonWorks® Quattro™ (Molecular Devices) for high-throughput electrophysiology, a PatchXpress® (Molecular Devices) and PatchLiner© (Nanion) systems for medium-throughput electrophysiology as well as two planar semi-automated Port-A-Patch® (Nanion) and numerous manual rigs.
This platform and know-how together with the screening library and Evotec’s medicinal chemistry expertise is accessible to Evotec’s alliance partners, providing a comprehensive approach for ion channel drug discovery.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Compound as Effective as FDA-Approved Drugs Against Life-Threatening InfectionsNews
Purdue University researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.READ MORE